MedPath

Center Eugene Marquis

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

30

Active:1
Completed:16

Trial Phases

4 Phases

Phase 1:1
Phase 2:7
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (26 trials with phase data)• Click on a phase to view related trials

Not Applicable
16 (61.5%)
Phase 2
7 (26.9%)
Phase 3
2 (7.7%)
Phase 1
1 (3.8%)

Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer

Not Applicable
Not yet recruiting
Conditions
High Risk Prostate Cancer
First Posted Date
2025-09-24
Last Posted Date
2025-09-24
Lead Sponsor
Center Eugene Marquis
Target Recruit Count
390
Registration Number
NCT07189598

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Not Applicable
Not yet recruiting
Conditions
Hepatocellular Carcinoma Non-resectable
Interventions
Device: Selective Internal Radiotherapy
First Posted Date
2025-08-14
Last Posted Date
2025-08-14
Lead Sponsor
Center Eugene Marquis
Target Recruit Count
80
Registration Number
NCT07122089

Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer

Not Applicable
Recruiting
Conditions
Otorhinolaryngeal Cancer
First Posted Date
2024-10-04
Last Posted Date
2025-02-13
Lead Sponsor
Center Eugene Marquis
Target Recruit Count
40
Registration Number
NCT06627075
Locations
🇫🇷

Centre de Lutte contre le Cancer Eugène Marquis, Rennes, Bretagne, France

Systematic Intervention to Improve Sexual Dysfunction

Not Applicable
Recruiting
Conditions
Breast Cancer Female
Localized Cancer
First Posted Date
2024-09-04
Last Posted Date
2025-08-05
Lead Sponsor
Center Eugene Marquis
Target Recruit Count
60
Registration Number
NCT06583460
Locations
🇫🇷

Centre de Lutte contre le Cancer Eugène Marquis, Rennes, Bretagne, France

Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma

Phase 2
Recruiting
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2024-08-13
Last Posted Date
2025-08-05
Lead Sponsor
Center Eugene Marquis
Target Recruit Count
34
Registration Number
NCT06551272
Locations
🇫🇷

CHU de Bordeaux, Bordeaux, France

🇫🇷

CHU de Nantes Hotel Dieu, Nantes, France

🇫🇷

hôpital Avicenne, Bobigny, France

and more 3 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.